Evidence map›Paper›PMID 39811125›Full record

ArticleACS medicinal chemistry letters2025

Novel Approaches in Biotechnology: Microbial Genetic Modifications and Metabolic Disease Therapies.

Robert B Kargbo

Abstract readEditorial
In one paragraph

Article in ACS medicinal chemistry letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Robert B KargboUsona Institute, Fitchburg, Wisconsin 53711-5300, United States.ORCID https://orcid.org/0000-0002-5539-6343

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in biotechnology have brought novel solutions to both metabolic diseases and sustainable agriculture. This Patent Highlight examines innovation from four recent patents focusing on the genetic modification of microbes for nitrogen and carbon fixation and the development of pharmaceutical compounds to target critical metabolic pathways. These breakthroughs have potential applications in fields ranging from industrial biotechnology and agriculture to cancer therapy and metabolic disease treatment, providing new strategies for addressing global health and environmental challenges.

Identifiers

PMID39811125
PMCPMC11726357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.